选择语言

Mouse Interferon-γ (IFN-γ) ELISPOT Kit

用户评价
货号-规格
价格
Qty.
RAS-SP002-96tests
¥3130.00
合计0件 产品金额¥ 0

产品详情

  • 组分(Materials Provided)

    ID
    Components
    Size
    RSP002-C01
    Pre-coated Anti-IFN-γ Antibody Microplate
    1 plate
    RSP002-C02
    Positive Stimulus
    60 μg
    RSP002-C03
    Biotin-Anti-IFN-γ Antibody
    50 μL
    RSP002-C04
    Streptavidin-HRP
    50 μL
    RSP002-C05
    Washing Buffer (10x)
    50 mL
    RSP002-C06
    Dilution Buffer (1x)
    50 mL
    RSP002-C07
    AEC Dilution
    25 mL
    RSP002-C08
    AEC Solution A (20x)
    0.8 mL
    RSP002-C09
    AEC Solution B (20x)
    0.8 mL
    RSP002-C10
    AEC Solution C (20x)
    0.8 mL

  • 产品概述(Product Overview)

    Interferon-γ (IFN-γ) is the only type II interferon. This proinflammatory cytokine is secreted by activated T cells and NK cells. It activates macrophages and endothelial cells and regulates immune responses by affecting APCs, T cells, and B cells. Production of IFN-γ by helper T cells and cytotoxic T cells is a hallmark of the Th1-type phenotype. Thus, high-level production of IFN-γ is typically associated with effective host defense against intracellular pathogens. The Mouse IFN-γ ELISpot assay is designed for the detection of mouse IFN-γ secreting cells at the single cell level and can be used to quantitate the frequency of mouse IFN-γ secreting cells. ELISpot assays are highly reproducible and sensitive, and can be used to measure responses with frequencies well below 1 in 100,000. ELISpot assays do not require prior in vitro expansion of T cells and they are suitable for high-throughput analysis using only small volumes of primary cells. As such, ELISpot assays are useful tools for research in vaccine development, cytokine secretion and the monitoring of various clinical trials.

  • 应用说明(Application)

    This kit is used to detect IFN-γ at the cellular level.

    It is for research use only.

  • 存储(Storage)

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • 原理(Assay Principles)

    ELISpot assays employ the quantitative sandwich enzyme-linked immunosorbent assay (ELISA) technique. The Kit consists of Pre-coated Anti-IFN-γ Antibody Microplate, Positive Stimulus, Biotin-Anti-IFN-γ Antibody, Streptavidin-HRP, AEC and buffers.

    Your experiment will include 6 simple steps:

    a) A monoclonal antibody specific for mouse IFN-γ has been pre-coated onto a polyvinylidene difluoride (PVDF)-backed microplate.

    b) Appropriately stimulated cells are pipetted into the wells and the microplate is placed into a humidified 37 °C CO2 incubator for a specified period of time.During this incubation period, the immobilized antibody in the immediate vicinity of the secreting cells binds secreted IFN-γ.

    c) After washing away any cells and unbound substances, a biotinylated antibody specific for mouse IFN-γ is added to the wells. Following a wash to remove any unbound biotinylated antibody, HRP conjugated to streptavidin is added.

    d) Wash the plate and add the Streptavidin-HRP diluted by Dilution Buffer to the plate.

    e) Wash the plate and add AEC. A reddish-brown colored precipitate forms and appears as spots at the sites of cytokine localization, with each individual spot representing an individual IFN-γ secreting cell.

    f) The spots can be counted with an automated ELISpot reader system or manually using a stereomicroscope.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

数据展示

  • 典型数据-Typical Data

    Please refer to DS document for the assay protocol.

     IFN-gamma TYPICAL DATA

    1x10⁵ cells/well Mouse Spleen Cells were stimulated with 6.0 μg/mL Positive Stimulus and cultured at 37℃ and 5%CO2 for 20 h, 308 spots were produced. The following example data is for reference only.

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    Interferon gamma

  • 中文全称:

    干扰素-γ

  • 种类:

  • 上市药物数量:

    3 详情

  • 临床药物数量:

    12 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
  • 产品基础信息
  • 产品详情
  • 数据展示
  • 用户评价